SELLAS Life Sciences
15 hedge funds and large institutions have $3.16M invested in SELLAS Life Sciences in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, reducing their positions, and 5 closing their positions.
4,000% more call options, than puts
Call options by funds: $164K | Put options by funds: $4K
51% more capital invested
Capital invested by funds: $2.1M → $3.16M (+$1.06M)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
7% more funds holding
Funds holding: 14 → 15 (+1)
0.08% more ownership
Funds ownership: 0.18% → 0.26% (+0.08%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
+$1.76M |
| 2 |
Renaissance Technologies
New York
|
+$580K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$245K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$108K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$23.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$41K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$34K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.42K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$414 |
SLS Hedge Fund Activity: Q3 2018 in Review
15 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in SELLAS Life Sciences (SLS) for Q3 2018, worth a combined $3.16M — up 51% from $2.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SLS positions and 5 closed out — a net gain of 1 holder — while 5 added to existing stakes and 0 trimmed.
The largest buyer was 683 Capital Management, opening a new position worth an estimated $1.76M. The largest seller was Virtu Financial, exiting entirely with an estimated $41K sold.
- 15 institutional investors held SELLAS Life Sciences (SLS) as of Q3 2018, up from 14 in Q2 2018.
- Funds reported $3.16M of SELLAS Life Sciences stock for Q3 2018, up 51% quarter-over-quarter.
- 6 funds opened new SELLAS Life Sciences positions in Q3 2018 and 5 closed out, a net change of +1 holder.
- The largest SELLAS Life Sciences buyer in Q3 2018 was 683 Capital Management, an estimated $1.76M added.
- The largest SELLAS Life Sciences seller in Q3 2018 was Virtu Financial, an estimated $41K sold.
Based on aggregated 13F filings for Q3 2018.